Disruption of Episiotomy. Disruption of perineal obstetric wound
Conditions
Interventions
Intervention 1: Intervention group: phenytoin sodium cream 1% of the drug distribution company Tehran - Iran and
Betadine solution purchased 10% of the pharmaceutical company's medipharm Kish - Iran.
Treatment - Drugs
Placebo
Intervention group: phenytoin sodium cream 1% of the drug distribution company Tehran - Iran and
Betadine solution purchased 10% of the pharmaceutical company's medipharm Kish - Iran
Control group: Placebo phenytoin sodium cream of the drug distribution company Tehran - Iran and
Betadine solution purchased 10% of the pharmaceutical company's medipharm Kish - Iran
Sponsors
Vice-Chancellor for Research of Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The women with 18-35 years old and full term pregnancy (37 to 42 weeks) being nulliparous; no specific diseases (cardiovascular; hepatic; renal; diabetes; coagulopathy diseases; anemia); non- obese (BMI<29; according to the same scale); singelton; cephalic presentation; episiotomy on gynecological bed; time of repair less than 30 minutes; episiotomy repair by chromic catgut sutures. exclusion criteria: Hematomas during and after the repair of episiotomy; extended Episiotomy; excessive bleeding after childbirth; manipulation of the perineum, uterus and cervixe; prolonged rupture of amniotic sac more than 18 hour; use of assistive devices (vacum during delivery); no smoking and alcohol.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Episiotomy wound healing. Timepoint: 24 hours, 5 and 10 days after delivery. Method of measurement: Reeda scale (redness, edema, ecchymosis, discharge, near the edge of the wound). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Pakniat
Qazvin University of Medical Sciences
Outcome results
None listed